Michael S. Cookson, MD, MMHC, University of Oklahoma College of Medicine, Norman, Oklahoma, discusses whether hormone sensitive, newly diagnosed metastatic prostate cancer patients should receive chemotherapy and androgen deprivation therapy.


Interview produced by Prostatepedia

Keywords: Metastatic Prostate Cancer, Chemotherapy, Androgen Deprivation Therapy, STAMPEDE, CHARTERED, French Study